94 completed, 43 unknown, 19 recruiting, 9 terminated. 186 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 186 | Completed 94, Unknown 43, Recruiting 19, Terminated 9, Not yet recruiting 7, Withdrawn 6, Active not recruiting 5, Enrolling by invitation 3 |
Follow Tablets: new trials by email Literature Review of Tablets trials Research Report on Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SGLT2i Therapy in Islet Transplantation (SIT) Empagliflozin 25 MG Oral Tablet, Empagliflozin 10 MG Oral Tablet [Jardiance] - Partial Islet Function, TPIAT | Phase 4 | Recruiting | University of Minnesota | 40 | 2026-07-21 | 2026-07-22 |
| Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis Acoramidis (AG10) oral tablet - Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis | Phase 4 | Recruiting | Eidos Therapeutics, a BridgeBio company | 150 | 2026-07-01 | 2026-07-29 |
| A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity Semaglutide 6 mg liquid emulsion formulation, Wegovy® (semaglutide) Tablet, Placebo liquid emulsion formulation - Obesity & Overweight | Phase 4 | Recruiting | Gila Therapeutics, Inc. | 40 | 2026-06-17 | 2026-07-27 |
| CANagliflozin In DIALysis Patients Invokana 300 mg and 100 mg tablet - Dialysis, Chronic Kidney Disease (Stages 4 and 5) | Phase 4 | Not yet recruiting | University Medical Center Groningen | 10 | 2026-06-01 | 2026-05-06 |
| Dapagliflozin in Active Lupus Nephritis Dapagliflozin (10Mg Tab) along with standard medical therapy, Placebo - Lupus Nephritis (LN) | Phase 4 | Recruiting | Brigham and Women's Hospital | 33 | 2026-05-22 | 2026-11-06 |
| Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome Atorvastatin 40 Mg Oral Tablet, Ezetimibe 10 mg, Bempedoic Acid 180 MG Oral Tablet - Acute Coronary Syndromes (ACS), Hypercholesterolemia | Phase 4 | Not yet recruiting | Punjab Institute of Cardology | 120 | 2026-05-01 | 2026-04-09 |
| Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy Imeglimin, Metformin 1000 mg Oral Tablet - Mitochondria, Metformin | Phase 4 | Not yet recruiting | Mansoura University | 176 | 2026-03-01 | 2026-02-27 |
| Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea Rifaximin 200 mg Tablet, Oral Rehydration Therapy (ORT) - Diarrhea, Gastroenteritis | Phase 4 | Recruiting | Bausch Health Americas, Inc. | 54 | 2026-02-11 | 2026-08-13 |
| A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) Dapagliflozin (10Mg Tab) along with standard medical therapy, Empagliflozin (25 Mg Tab) along with standard medical therapy - Type 2 Diabetes | Phase 4 | Not yet recruiting | Bhavya Bhavya, MD | 112 | 2025-12-24 | 2025-12-31 |
| Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications Lomaira 8Mg Tablet - Weight Loss, Obesity, Childhood | Phase 4 | Withdrawn | Loma Linda University | 2025-12-01 | 2025-11-20 | |
| Efficacy of Methylprednisolone for Pain Control After ACL Repair Meloxicam 15 mg, Medrol 4 MG Oral Tablet Includes Medrol Dosepak, Gabapentin 300 mg - ACL Surgery, Pain Management | Phase 4 | Recruiting | St. Louis University | 90 | 2025-10-21 | 2025-10-24 |
| Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New Injuries Methylprednisolone 4Mg Tab, Acetaminophen 500Mg Tab, Ibuprofen 200Mg Oral Tablet - Musculoskeletal Pain | Phase 4 | Enrolling by invitation | State University of New York at Buffalo | 60 | 2025-09-17 | 2026-10-16 |
| Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM) Bortezomib + Lenalidomide + Dexamethasone + Fenofibrate 160 mg tablet, Bortezomib + Lenalidomide + Dexamethasone - Peripheral Neuropathy, Multiple Myeloma, Neoplasms | Phase 4 | Recruiting | Tanta University | 44 | 2025-08-30 | 2025-11-04 |
| The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically Adderall 10Mg Tablet, Placebo - Prescription Stimulants, Expectations | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2025-07-01 | 2025-04-07 | |
| Computational Assessment of GABA Receptor Modulation in PTSD Lorazepam 1 mg tablet, Placebo tablet - Stress Disorders, Post-Traumatic | Phase 4 | Recruiting | VA Office of Research and Development | 150 | 2025-07-01 | 2026-06-16 |
| Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study Avatrombopag 20 mg Oral Tablet - ITP - Immune Thrombocytopenia | Phase 4 | Recruiting | Al-Mustansiriyah University | 25 | 2025-06-08 | 2025-08-21 |
| A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan Bempedoic acid 180 mg tablet - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 4 | Completed | Daiichi Sankyo | 180 | 2025-04-01 | 2025-12-08 |
| Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation Moxidectin 2 MG Oral Tablet, Placebo - Blepharitis | Phase 4 | Completed | Eye Research Foundation, Inc. | 24 | 2025-02-02 | 2025-08-12 |
| Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease Vortioxetine (tablet) - Parkinson Disease, Idiopathic, Freezing of Gait | Phase 4 | Not yet recruiting | Marianna Amboni | 40 | 2025-02-01 | 2025-02-06 |
| Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody Levothyroxine Sodium (LT4) Tablets, Placebo - Thyroid Abnormalities, Pregnant Woman | Phase 4 | Not yet recruiting | Yang ZHANG | 400 | 2024-10-25 | 2024-10-23 |
Showing 20 of 186. Sign in to see all of them.
Diabetes Mellitus, Type 2 (15) · Pain, Postoperative (8) · Hypertension (6) · Atrial Fibrillation (5) · Cognitive Dysfunction (5) · Coronary Artery Disease (5) · Diabetes Mellitus (5) · Obesity (5) · Pain (5) · Acquired Immunodeficiency Syndrome (4) · Acute Coronary Syndrome (4) · Cardiovascular Diseases (4) · HIV Infections (3) · Metabolic Syndrome (3) · Osteoarthritis, Knee (3)
Ain Shams University (6) · Beni-Suef University (3) · Damanhour University (3) · Tanta University (3) · Assiut University (2) · Chong Kun Dang Pharmaceutical (2) · Damascus Hospital (2) · James J. Peters Veterans Affairs Medical Center (2) · Jun Li (2) · Loma Linda University (2) · Mansoura University (2) · National Cheng-Kung University Hospital (2) · Primus Pharmaceuticals (2) · The University of Hong Kong (2) · University of Alabama at Birmingham (2)
United States (44) · Egypt (25) · China (9) · South Korea (7) · Turkey (Türkiye) (7) · United Kingdom (6) · Denmark (5) · Germany (5) · Brazil (4) · Canada (4) · Spain (4) · Taiwan (4) · Belgium (3) · India (3) · Italy (3)
Jie Wang, MD (2) · John P Handrakis, PT, DPT, EdD (2) · John Thyfault, PhD (2) · AK Azad Chowdhury, PhD (1) · Aleksa B Markovic (1) · Alexa Hollinger, MD (1) · Ashraf M Alaa, BSc of clinical pharmacy (1) · Asmaa A Elsayed, Master (1) · Begum Rokeya, PhD (1) · Bill Cameron, MD (1)
PMID 20432394, PMID 20531008, PMID 20681275, PMID 22019563, PMID 23303884, PMID 27480425, PMID 27847338, PMID 10347109, PMID 11020772, PMID 11163814, PMID 11383749, PMID 11393894, PMID 11519503, PMID 11587154, PMID 11726570, PMID 11772973, PMID 11782957, PMID 12097797, PMID 12438935, PMID 12640353, PMID 12748199, PMID 15346752, PMID 15596866, PMID 16022079, PMID 16190504, PMID 16243238, PMID 16249960, PMID 16271642, PMID 16403930, PMID 16460491, PMID 16876158, PMID 17496462, PMID 17508035, PMID 17578977, PMID 17698200, PMID 17718279, PMID 17920917, PMID 17935805, PMID 18085470, PMID 18251131, PMID 18292756, PMID 18307181, PMID 18325025, PMID 18410283, PMID 18492024, PMID 18547224, PMID 18929133, PMID 19029956, PMID 19171788, PMID 19225527
2017 (2), 2019 (2), R01AR071263 (2), 2009 (1), 2015 (1), 2016 (1), 2025 (1), R03DK140415 (1), U19AG065188 (1)